152 related articles for article (PubMed ID: 17137250)
1. [Molecular markers of head and neck cancer].
Temam S; Janot F
Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
[TBL] [Abstract][Full Text] [Related]
2. New molecular diagnostic methods in head and neck cancer.
Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
[TBL] [Abstract][Full Text] [Related]
3. Role of molecular markers in the management of head and neck cancers.
Ferreira MB; De Souza JA; Cohen EE
Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
[TBL] [Abstract][Full Text] [Related]
4. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
5. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.
van Houten VM; Tabor MP; van den Brekel MW; Denkers F; Wishaupt RG; Kummer JA; Snow GB; Brakenhoff RH
Clin Cancer Res; 2000 Oct; 6(10):3803-16. PubMed ID: 11051222
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers for diagnosis and prognosis.
Partridge M; Gaballah K; Huang X
Cancer Metastasis Rev; 2005 Jan; 24(1):71-85. PubMed ID: 15785873
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on the molecular epidemiology of aerodigestive tract cancers.
Hung RJ; van der Hel O; Tavtigian SV; Brennan P; Boffetta P; Hashibe M
Mutat Res; 2005 Dec; 592(1-2):102-18. PubMed ID: 16023150
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
[TBL] [Abstract][Full Text] [Related]
9. Biological agents in head and neck cancer.
Bossi P; Locati LD; Licitra L
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1643-50. PubMed ID: 18020930
[TBL] [Abstract][Full Text] [Related]
10. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
11. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes, molecular biology and the head and neck surgeon.
Irish JC
J Otolaryngol; 1992 Dec; 21 Suppl 3():1-20. PubMed ID: 1289578
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cancer: proteomic advances and biomarker achievements.
Rezende TM; de Souza Freire M; Franco OL
Cancer; 2010 Nov; 116(21):4914-25. PubMed ID: 20665484
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer].
Kopczyński P; Flieger R
Pol Merkur Lekarski; 2013 Jul; 35(205):37-8. PubMed ID: 23984603
[TBL] [Abstract][Full Text] [Related]
15. Hereditary and environmental factors associated with risk and progression of head and neck cancer.
Trizna Z; Schantz SP
Otolaryngol Clin North Am; 1992 Oct; 25(5):1089-103. PubMed ID: 1408193
[TBL] [Abstract][Full Text] [Related]
16. [The molecular marker eIF4E in the surgical margins of the resection preparations of head-neck tumors as a prognostic factor].
Ernst-Stecken A
Strahlenther Onkol; 2000 Aug; 176(8):383-4. PubMed ID: 10987024
[No Abstract] [Full Text] [Related]
17. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
18. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
19. Identification of clinically useful cancer prognostic factors: what are we missing?
McShane LM; Altman DG; Sauerbrei W
J Natl Cancer Inst; 2005 Jul; 97(14):1023-5. PubMed ID: 16030294
[No Abstract] [Full Text] [Related]
20. Molecular approaches to the staging of head and neck carcinomas (review).
Gasparotto D; Maestro R
Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
